Search
for
Sort by
Research 151–180 of 399
- Association between stress and bilateral symmetrical alopecia in free-ranging Formosan macaques in Mt. Longevity, Taiwan
- Nonclassic congenital adrenal hyperplasia and the heterozygote carrier
- Hair and Nails
- Is dehydroepiandrosterone a hormone?
- Neuroimmunology of Stress: Skin Takes Center Stage
- Stress-Induced Deoxycorticosterone-Derived Neurosteroids Modulate GABA<sub>A</sub>Receptor Function and Seizure Susceptibility
- Screening for 21-hydroxylase–deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study
- Dermatoses of pregnancy
- Sex differences in the hypothalamic–pituitary–adrenal axis’ response to stress: an important role for gonadal hormones
- An Update of Congenital Adrenal Hyperplasia
- Physiologic skin changes in pregnancy
- Neurogenic Inflammation in Stress-Induced Termination of Murine Hair Growth Is Promoted by Nerve Growth Factor
- Obesity and polycystic ovary syndrome
- Neurosteroids, neuroactive steroids, and symptoms of affective disorders
- Safety of testosterone treatment in postmenopausal women
- Semen Parameters Among Transgender Women With a History of Hormonal Treatment
- PHYSIOLOGIC SKIN CHANGES ASSOCIATED WITH PREGNANCY
- Recent advances in the molecular mechanisms determining tissue sensitivity to glucocorticoids: novel mutations, circadian rhythm and ligand-induced repression of the human glucocorticoid receptor
- Polycystic ovary syndrome and insulin-resistant hyperinsulinemia
- An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner
- Relationships between cerebrospinal fluid GABAergic neurosteroid levels and symptom severity in men with PTSD
- Chrousos syndrome: from molecular pathogenesis to therapeutic management
- 5α-Reduced glucocorticoids: a story of natural selection
- Clinical and histopathologic features of hair loss in patients with HIV-1 infection
- 11 Treatment of hirsutism and acne with cyproterone acetate
- Evidence-based approach to cutaneous hyperandrogenism in women
- Cushing Syndrome from Percutaneous Absorption of 1% Hydrocortisone Ointment in Netherton Syndrome
- Polycystic Ovary Syndrome and Its Differential Diagnosis
- Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess
- GLI2-specific Transcriptional Activation of the Bone Morphogenetic Protein/Activin Antagonist Follistatin in Human Epidermal Cells